Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma

Han Si; Jimin Zhang; Monica Wielgos-Bonvallet; Lorenzo Falchi; Kim Linton; Wojciech Jurczak; David Belada; Isil Altintas; Mariana Sacchi; Elena Favaro; Ali Rana; Daniela Hoehn; David Soong; Christopher W. Chiu; Maria Jure-Kunkel

doi:10.1158/1538-7445.AM2024-3732

Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma

Han Si, Jimin Zhang, Monica Wielgos-Bonvallet, Lorenzo Falchi, Kim Linton, Wojciech Jurczak, David Belada, Isil Altintas, Mariana Sacchi, Elena Favaro, Ali Rana, Daniela Hoehn, David Soong, Christopher W. Chiu, Maria Jure-Kunkel

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	3732
Number of pages	2
Journal	Cancer Research
Volume	84
Issue number	6_Supplement
Early online date	15 Mar 2024
DOIs	https://doi.org/10.1158/1538-7445.AM2024-3732
Publication status	Published - 22 Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1538-7445.AM2024-3732

Cite this

Si, H., Zhang, J., Wielgos-Bonvallet, M., Falchi, L., Linton, K., Jurczak, W., Belada, D., Altintas, I., Sacchi, M., Favaro, E., Rana, A., Hoehn, D., Soong, D., Chiu, C. W., & Jure-Kunkel, M. (2024). Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma. Cancer Research, 84(6_Supplement), Article 3732. https://doi.org/10.1158/1538-7445.AM2024-3732

@article{9503f20451e84cd8ad2ea42d2490a5b4,

title = "Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma",

author = "Han Si and Jimin Zhang and Monica Wielgos-Bonvallet and Lorenzo Falchi and Kim Linton and Wojciech Jurczak and David Belada and Isil Altintas and Mariana Sacchi and Elena Favaro and Ali Rana and Daniela Hoehn and David Soong and Chiu, {Christopher W.} and Maria Jure-Kunkel",

year = "2024",

month = mar,

day = "22",

doi = "10.1158/1538-7445.AM2024-3732",

language = "English",

volume = "84",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "6_Supplement",

}

Si, H, Zhang, J, Wielgos-Bonvallet, M, Falchi, L, Linton, K, Jurczak, W, Belada, D, Altintas, I, Sacchi, M, Favaro, E, Rana, A, Hoehn, D, Soong, D, Chiu, CW & Jure-Kunkel, M 2024, 'Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma', Cancer Research, vol. 84, no. 6_Supplement, 3732. https://doi.org/10.1158/1538-7445.AM2024-3732

TY - JOUR

T1 - Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma

AU - Si, Han

AU - Zhang, Jimin

AU - Wielgos-Bonvallet, Monica

AU - Falchi, Lorenzo

AU - Linton, Kim

AU - Jurczak, Wojciech

AU - Belada, David

AU - Altintas, Isil

AU - Sacchi, Mariana

AU - Favaro, Elena

AU - Rana, Ali

AU - Hoehn, Daniela

AU - Soong, David

AU - Chiu, Christopher W.

AU - Jure-Kunkel, Maria

PY - 2024/3/22

Y1 - 2024/3/22

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001252656306401&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1158/1538-7445.AM2024-3732

DO - 10.1158/1538-7445.AM2024-3732

M3 - Meeting Abstract

SN - 0008-5472

VL - 84

JO - Cancer Research

JF - Cancer Research

IS - 6_Supplement

M1 - 3732

ER -

Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma

UN SDGs

Access to Document

Other files and links

Cite this